Masayuki Kitajima
Overview
Explore the profile of Masayuki Kitajima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
661
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kasuya T, Tanaka S, Tamura J, Etori K, Shoda J, Hattori K, et al.
Sci Rep
. 2023 Jan;
13(1):1653.
PMID: 36717741
Epithelial cells control a variety of immune cells by secreting cytokines to maintain tissue homeostasis on mucosal surfaces. Regulatory T (Treg) cells are essential for immune homeostasis and for preventing...
2.
Kitajima M, Kubo M, Ziegler S, Suzuki H
J Immunol
. 2020 May;
205(1):27-35.
PMID: 32444388
Thymic stromal lymphopoietin (TSLP) is a key cytokine that initiates and promotes allergic inflammation both in humans and mice. It is well known that TSLP is important in initial step...
3.
Abe Y, Sakuyama N, Sato T, Kishine K, Nagayasu K, Nakatani A, et al.
Mol Clin Oncol
. 2019 Aug;
11(3):289-295.
PMID: 31396387
5-Fluorouracil (5-FU) dosing has traditionally been based on the body surface area (BSA) in colorectal cancer treatment. However, there is accumulating evidence that dosing based on BSA may be of...
4.
Ochiai T, Nishimura K, Watanabe T, Kitajima M, Nakatani A, Nagayasu K, et al.
Oncol Lett
. 2019 Jan;
17(2):1842-1850.
PMID: 30675246
In recent studies, better clinical outcomes for patients with left-sided colon cancer (CC) compared with right-sided CC have been reported; however, in such investigations, the chemotherapy regimens included molecular-targeting agents....
5.
Kimura A, Kitajima M, Nishida K, Serada S, Fujimoto M, Naka T, et al.
J Exp Med
. 2018 Jun;
215(8):2197-2209.
PMID: 29934320
NAD(P)H:quinone oxidoreductase 1 (NQO1) protects cells against oxidative stress and toxic quinones. In this study, we found a novel role of NQO1 in suppressing Toll-like receptor (TLR)-mediated innate immune responses....
6.
Kitajima M, Kimura A, Suzuki H
J Immunol
. 2018 Jan;
200(5):1555-1559.
PMID: 29378915
Irritant contact dermatitis (ICD) is associated with local release of inflammatory mediators such as reactive oxygen species and regulated by various antioxidative enzymes and antioxidants. Although Nqo1 is involved in...
7.
Muro R, Nitta T, Kitajima M, Okada T, Suzuki H
Biochem Biophys Res Commun
. 2018 Jan;
496(1):25-30.
PMID: 29291408
Fine regulation of the Ras/mitogen-activating protein kinase (MAPK) pathway is crucial in controlling the survival, proliferation, and development of various types of cells. Ras-activating protein-like 3 (Rasal3) is a T...
8.
Ochiai T, Nishimura K, Watanabe T, Kitajima M, Nakatani A, Nagayasu K, et al.
Oncol Lett
. 2017 Nov;
14(5):6045-6052.
PMID: 29113244
Leucovorin (FOL) and fluorouracil (5-FU) plus oxaliplatin (l-OHP; FOLFOX) or FOL and 5-FU plus irinotecan (SN-38; FOLFIRI) are widely used as first-line chemotherapy regimens in the treatment of advanced colorectal...
9.
Takikita S, Muro R, Takai T, Otsubo T, Kawamura Y, Dohi T, et al.
J Immunol
. 2016 Aug;
197(6):2269-79.
PMID: 27511731
ESET/SETDB1, one of the major histone methyltransferases, catalyzes histone 3 lysine 9 (H3K9) trimethylation. ESET is critical for suppressing expression of retroviral elements in embryonic stem cells; however, its role...
10.
Chang M, Suzuki T, Kitajima M, Takaku H
AIDS Res Hum Retroviruses
. 2015 Jul;
31(10):1023-31.
PMID: 26178669
Acquired immune deficiency syndrome (AIDS) is mainly caused by infection with human immunodeficiency virus-1 (HIV-1) and still poses a global threat for which we lack a protective or therapeutic vaccine....